4
Changes in Ownership
BOSTON SCIENTIFIC CORP Filed Acc 0001225208-24-009728
Chairman, President & CEO sold 162,778 shares at an average $84.75 ($13,794,851)
- Chairman, President & CEO acquired 111,887 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Mahoney Michael F · Chairman, President & CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +56,211 | $17.26 | $970,202 | 1,628,307 | D |
| 2024-11-05 | Exercise or conversion : show line 2 in the form 10b5-1 | +55,676 | $16.31 | $908,076 | 1,683,983 | D |
| 2024-11-05 | Sale : show line 3 in the form 10b5-1 | −2,596 | $85.17 | $221,108 | 1,681,387 | D |
| 2024-11-05 | Sale : show line 4 in the form 10b5-1 | −160,182 | $84.74 | $13,573,743 | 1,521,205 | D |
| Open-market sales · 162,778 sh · avg $84.75 · $13,794,851 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-05 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −56,211 | 168,635 | D |
| 2024-11-05 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −55,676 | 0 | D |
Loading xslF345X05/doc4.xml…